Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Science, Linköping University, Linköping, Sweden.
Am J Sports Med. 2022 Apr;50(5):1306-1316. doi: 10.1177/03635465221077101. Epub 2022 Mar 2.
Corticosteroid treatments such as dexamethasone are commonly used to treat tendinopathy but with mixed outcomes. Although this treatment can cause tendon rupture, it can also stimulate the tendon to heal. However, the mechanisms behind corticosteroid treatment during tendon healing are yet to be understood.
To comprehend when and how dexamethasone treatment can ameliorate injured tendons by using a rat model of Achilles tendon healing.
Controlled laboratory study.
An overall 320 rats were used for a sequence of 6 experiments. We investigated whether the drug effect was time-, dose-, and load-dependent. Additionally, morphological data and drug administration routes were examined. Healing tendons were tested mechanically or used for histological examination 12 days after transection. Blood was collected for flow cytometry analysis in 1 experiment.
We found that the circadian rhythm and drug injection timing influenced the treatment outcome. Dexamethasone treatment at the right time point (days 7-11) and dose (0.1 mg/kg) significantly improved the material properties of the healing tendon, while the adverse effects were reduced. Local dexamethasone treatment did not lead to increased peak stress, but it triggered systemic granulocytosis and lymphopenia. Mechanical loading (full or moderate) is essential for the positive effects of dexamethasone, as complete unloading leads to the absence of improvements.
We conclude that dexamethasone treatment to improve Achilles tendon healing is dose- and time-dependent, and positive effects are perceived even in a partly unloaded condition.
These findings are promising from a clinical perspective, as the positive effect of this drug was seen even when given at lower doses and in a moderate loading condition, which better mimics the load level in patients with tendon ruptures.
地塞米松等皮质类固醇治疗常用于治疗腱病,但疗效不一。虽然这种治疗方法可能导致肌腱断裂,但也能刺激肌腱愈合。然而,皮质类固醇治疗在肌腱愈合过程中的作用机制尚不清楚。
通过使用跟腱愈合的大鼠模型,了解地塞米松治疗如何改善受损的肌腱,以及何时、如何发挥作用。
对照实验室研究。
总共使用了 320 只大鼠进行了一系列 6 项实验。我们研究了药物作用是否与时间、剂量和负荷有关。此外,还检查了形态学数据和药物给药途径。在切断后 12 天,对愈合的肌腱进行机械测试或用于组织学检查。在 1 项实验中收集血液进行流式细胞术分析。
我们发现,昼夜节律和药物注射时间影响治疗效果。在正确的时间点(第 7-11 天)和剂量(0.1mg/kg)对地塞米松治疗可显著改善愈合肌腱的力学性能,同时减少不良反应。局部地塞米松治疗不会导致峰值应力增加,但会引发全身粒细胞增多和淋巴细胞减少。机械负荷(完全或适度)对地塞米松的积极作用至关重要,因为完全卸载会导致没有改善。
我们得出结论,地塞米松治疗改善跟腱愈合是剂量和时间依赖性的,即使在部分卸载的情况下也能观察到积极的效果。
这些发现从临床角度来看是有希望的,因为即使在较低剂量和适度负荷条件下,这种药物的积极作用仍然存在,这更能模拟肌腱断裂患者的负荷水平。